Piper Sandler lowered the firm’s price target on Bed Bath & Beyond to $8 from $10 and kept a Neutral rating on the shares following a Q4 print that showed sequential improvement in the core business. While revenue was still down year-over-year, internal initiatives such as SKU consolidation appear to be gaining traction, Piper notes. The firm remains on the sidelines given the amount of uncertainty in bringing its three-pillar framework together.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BBBY:
- Balancing Stabilized Core Operations and High-Risk Growth Initiatives: Justifying a Hold on Bed Bath & Beyond
- Closing Bell Movers: Keysight rallies 15% after earnings beat
- Bed Bath & Beyond reports Q4 EPS (30c), consensus (22c)
- Bed Bath & Beyond sees FY26 revenue trends up low-mid single digits
- Bed Bath & Beyond Inc options imply 13.5% move in share price post-earnings